style='font-family:Verdana;'> style='font-family:Verdana;'> Bone metastasis with advance cancer stage form style='font-family:Verdana;'> style='font-family:'/> Identification of the Risk Factors of Bone Metastatic among Breast Cancer Women in Al-Bashir Hospital
首页> 外文期刊>Advances in Breast Cancer Research >Identification of the Risk Factors of Bone Metastatic among Breast Cancer Women in Al-Bashir Hospital
【24h】

Identification of the Risk Factors of Bone Metastatic among Breast Cancer Women in Al-Bashir Hospital

机译:Al-Bashir医院乳腺癌女性骨转移的危险因素的确定

获取原文
       

摘要

>Background: style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;"> Bone metastasis with advance cancer stage form style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;">s style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;"> approximately 85% of all cases. Breast cancer patients frequently suffer from bone pain, functional impairment due to bone metastasis which impact style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;">s>> style="font-family:""> style="font-family:Verdana;"> negatively on their quality of life. style="font-family:Verdana;">Subjects and Methods: style="font-family:Verdana;"> A retrospective study of breast cancer patients who have bone metastasis at diagnosis or developing bone metastasis during 5 years from breast cancer diagnosis (2011-2016) and who received zometa 4>> style="font-family:""> style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;">mg monthly in radiotherapy department w style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;">as style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;"> included and conducted in 2017. We reviewed 107 female with breast cancer diagnosed by bone scan and/or PET scan as cases of bone metastasis enrolled. Questionnaire was designed to document all variables besides, demographic data which contain (age, histopathology reading invasive ductal carcinoma,>> style="font-family:""> style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;">invasive lobular carcinoma or others,>> style="font-family:""> style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;">ER status, PR status, Her2neu status and l style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;">y>> style="font-family:""> style="font-family:Verdana;">mph node status & stage, Onset of metastasis, Menopausal Status & finally No. of metastasis site). style="font-family:Verdana;">Results:>> style="font-family:""> style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;">We noticed that the highest percentage of patients diagnosed as bone metastasis were 45 years style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;"> and more, style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;"> and 86% of them were invasive ductal carcinoma style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;">; style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;">regarding hormonal status we noticed that ER, PR status was positive in 90.7% and 82.2% of cases respectively, Her2neu receptors were amplified in 26.2% of them, positive lymph nodes style="font-family:Verdana;"> style="font-family:Verdana;"> style="font-family:Verdana;">were style="font-family
机译:>背景: style =“ font-family:Verdana;”> style =“ font-family:Verdana;”> style =“ font-family:Verdana;”>骨转移患有癌症的晚期分期形式 style =“ font-family:Verdana;”> style =“ font-family:Verdana;”> style =“ font- family:Verdana;“> s style =” font-family:Verdana;“> style =” font-family:Verdana;“> style =” font-family:Verdana;“>大约占所有案例的85%。乳腺癌患者经常患有骨痛,由于骨转移引起的功能受损,从而影响 style =“ font-family:Verdana;”> style =“ font-family :Verdana;“> style =” font-family:Verdana;“> s > > style =” font-family:“”> < style =“ font-family:Verdana;”>主题和方法: style =“ font-family:Verdana;”>对在乳腺癌诊断后5年内(2011-2016年)诊断为骨转移或发生骨转移并接受zometa 4治疗的乳腺癌患者的回顾性研究。 span> > > style =“ font-family:”“> style =” font -family:Verdana;“> style =” font-family:Verdana;“> style =” font-family:Verdana;“>在放射治疗部门每月mg style =“ font-family:Verdana;”> style =“ font-family: Verdana;“> style =” font-family:Verdana;“>如 style =” font-family:Verdana;“> style =” font-家庭:Verdana;“> style =” font-family:Verdana;“>于2017年纳入并进行。我们纳入了107名经骨扫描和/或PET扫描诊断为乳腺癌的女性,作为骨转移病例。问卷旨在记录所有变量,除了人口统计数据外,还包含(年龄,组织病理学,浸润性导管癌, > > style =“ font-family:” “> style =” font-family:Verdana;“> style =” font-family:Verdana;“> style =” font-family:Verdana ;“>侵袭性小叶癌或其他, > > style =” font-family:“”> style =“ font-family:Verdana;”> style =“ font-family:Verdana;”> style =“ font-family:Verdana;”> ER状态,PR状态,Her2neu状态和l style =“ font-family:Verdana;”> style =“ font-family:Verdana;”> style =“ font-family:Verdana;” > y > > style =“ font-family:”“> style =” font-family:Verdana;“> mph节点状态和阶段,转移的发生,更年期状态和转移部位的最终数目)。 style =“ font-family:Verdana;”>结果: > > style =“ font-family:”“> style =” font-family:Verdana;“> < span style =“ font-family:Verdana;”> style =“ font-family:Verdana;”>我们注意到,被诊断为骨转移的患者中,最高比例为45岁 style =“ font-family:Verdana;”> style =“ font-family:Verdana;”> style =“ font-family:Verdana;”>等, style =“ font-family:Verdana;”> style =“ font-family:Verdana;”> style =“ font-family:Verdana;”>和其中的86%是浸润性导管癌 style =“ font-family:Verdana;”> style =“ font-family:Verdana;”> style =“ font-family :Verdana;“>; style =“ font-family:Verdana;”> style =“ font-family:Verdana;”> style =“ font-family:Verdana;” >关于激素状况,我们注意到ER,PR状况分别为90.7%和82.2%阳性,其中Her2neu受体在26.2%的情况中被扩增,淋巴结阳性 style =“ font-family:Verdana;”> style =“ font-family:Verdana;”> style =“ font-family:Verdana;”>是 style =“ font-family

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号